ziftomenib: a menin inhibitor for r/r npm1-mutated aml
Published 10 months ago • 379 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
3:46
update on komet-001: identifying the optimal dose of ziftomenib for patients with r/r aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
2:17
updated analysis of bellwave-001: nemtabrutinib in r/r cll
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
6:11
i-box - central line blood sampling
-
5:23
set up installation
-
2:46
welcome to blood talks
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
2:43
diagnostic tools for aml
-
1:32
an update from bellwave-001: nemtabrutinib in cll/sll
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
0:54
azintuxizumab vedotin for r/r multiple myeloma
-
1:21
intensive therapy of older aml
-
1:56
minimal gene panel in aml
-
3:37
2020 uk aml trials update
-
3:22
chromothripsis and chromoplexy in myeloma
-
3:40
master class in transplantation and hematology: highlights
-
1:45
role for mrd assessment in al amyloidosis?
-
1:45
gvhd & gvl in secondary aml